One of the top ten global pharmaceutical companies digitizes their logbooks across the organization, through ValGenesis eLog
San Francisco, August 24, 2021: ValGenesis, Inc., a market leader…
ValGenesis Inc., Announces New VP of Marketing to Join its Executive Team
San Francisco, August 9, 2021: ValGenesis, Inc., a market leader…
ValGenesis Inc. Announces the Appointment of Kevin O’Donnell as Chief Financial Officer
San Francisco, August 2, 2021: ValGenesis, Inc., the market leader…
Top Italian Life Sciences Company selects ValGenesis’ SaaS platform to digitally manage its validation processes
San Francisco, June 15, 2021 – ValGenesis Inc., a market…
ValGenesis Inc. Secures $24 Million Investment from Morgan Stanley Expansion Capital
San Francisco, May 04, 2021 ValGenesis, Inc., the market leader…
American cell therapies company selects ValGenesis VLMS to digitize multiple validation lifecycle processes
San Francisco, January 25, 2021: ValGenesis Inc., a market leader…
International biosciences company to digitize validation processes for its clients across 40 countries, driven by ValGenesis VLMS
San Francisco, January 20, 2021: ValGenesis, Inc., a market leader…
Pioneering Gene Therapy Company selects ValGenesis’s SaaS platform to digitize its global validation programs
San Francisco, January 6, 2021: ValGenesis, Inc., a market leader…
ValGenesis collaborates with Biocon Biologics for digital validation across multiple sites
San Francisco, December 15, 2020: ValGenesis Inc., a market leader…
